<div id="readability-page-1"><div>Assertio Investor Alert: Kahn Swick &amp; Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc. - ASRTFormer Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick &amp; Foti, LLC (“KSF”) are investigating the proposed sale of Assertio Holdings, Inc. (NasdaqCM: ASRT) to Garda Therapeutics. Under the terms of the proposed transaction, shareholders of Assertio will receive $18.00 per share in cash and a contingent value right. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-asrt/ to learn more.Please note that the transaction is structured as a tender offer, such that time may be of the essence.To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn <img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNjA1MTk4NzY2NzZyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNjA1MTk4NzY2NzZyMQ"/>Kahn Swick &amp; Foti, LLC Lewis Kahn, Managing Partner lewis.kahn@ksfcounsel.com 855-768-1857 1100 Poydras St., Suite 960 New Orleans, LA 70163View source version on businesswire.com: https://www.businesswire.com/news/home/20260519876676/en/</div></div>

ASRT

Kahn Swick & Foti, LLC 正在調查 Assertio Holdings, Inc. (ASRT) 擬議出售給 Garda Therapeutics 的事宜，股東將獲得每股 18.00 美元。該公司旨在評估這一價格的合理性及其形成過程，質疑是否低估了該公司。感興趣的各方可以聯繫 KSF 獲取更多信息

Assertio 投資者警示：Kahn Swick & Foti, LLC 正在調查擬議出售 Assertio Holdings, Inc. - ASRT 的價格和流程是否合理